Sponsor Pipeline

dr. Tom van der Hulle Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07077161 Cabozantinib Dose Skipping as an Alternative to Dose Reductions Renal Cell Carcinoma (RCC) Recruiting
Disease Areas
Kidney Cancer (1)
Get alerts when dr. Tom van der Hulle's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free